Observational studySupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024
Quality of end-of-life care in patients with hematological malignancies: potential role of palliative care.
Observational study in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Potentially burdensome end-of-life care for colorectal cancer decedents: A retrospective cohort study.Palliative & supportive care · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLimited data are available on the impact of specialist palliative care on end-of-life care quality for patients with hematologic malignancies. This study aims to analyze the quality of end-of-life care in patients with hematological malignancies, comparing those who receive palliative care with those who do not.
methodsObservational, single center retrospective study. This study was conducted at the National Cancer Institute (INCan) in Mexico City, a tertiary care hospital, between January 2016 and June 2021. This study included deceased patients with hematological malignancies who were hospitalized or patients who were hospitalized and receiving home palliative care, with follow-up from the palliative care service. End-of-life care quality was assessed using the ASCO/NQF instrument.
resultsThree hundred sixty deceased patients with hematological malignancies were included in the analysis; 51.4% were men, with a median age of 52 years. The most common diagnosis was non-Hodgkin lymphoma (41.4%); 37.8% of patients were referred to palliative care, with an average referral time from admission to INCan of 99.5 days. Patients without palliative care referral showed worse quality of death indicators (71.6% vs. 28.4%). Survival analysis revealed a median survival of 5.29 months for patients with up to 3 worse quality of death indicators and 3.65 months for those with ≥ 4 worse quality of death indicators at the end-of-life (p < 0.001).
conclusionPatients with hematologic malignancies who did not receive palliative care experienced more intensive end-of-life interventions and had lower overall survival rates. Early integration of palliative care is crucial to promote compassionate approaches near death and ensure quality end-of-life care.
Indexed as
Identifiers
39607499What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.